Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Session 5 – The Management of Advanced Disease: Targeted Therapies and New Treatment

Targeted Therapies Beyond FGFR and IDH: Current Data and Compounds in Advanced (Phase II and Beyond) Stage of Development

Date

25 Oct 2024

Session

Session 5 – The Management of Advanced Disease: Targeted Therapies and New Treatment

Topics

Targeted Therapy

Tumour Site

Hepatobiliary Cancers

Presenters

C. Braconi, UK

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.